Creatine Therapy for Huntington's Disease

Completed · Phase 1/Phase 2

Conditions studied: Huntington's Disease

In brief

This study, CREST-HD, will examine the safety and tolerability of 8 grams of creatine in subjects affected by Huntington's disease (HD). Biochemistry and neuroimaging will be used to examine the potential effects of creatine on HD.

Key facts

Study ID

NCT00026988

Run by

National Center for Complementary and Integrative Health (NCCIH)

People needed

64

Starts

2001-10-01

Expected to finish

2006-06-01

Last updated by the study team

2006-08-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Steven Hersch, M.D., Ph.D. — Boston, Massachusetts, United States
• Andrew Feigin, M.D. — Long Island City, New York, United States
• Karen Marder, M.D. — New York, New York, United States
• Peter Como, Ph.D. — Rochester, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.